Table 3.
Complications and sequelae of gastroenteritis
| condition | associated pathogens | ^risk/predispositions | references |
|---|---|---|---|
| bacteremia; extraintestinal infections | non-typhoidal Salmonella>Campylobacter, Yersinia | elderly, immunosuppressed infants, young children, mutations in TLR genes, immunocompromised adults in LMICsa |
95 |
| intestinal perforation, toxic megacolon | Shigella dysenteriae, infrequently complicates infection with other Shigella serotypes and other etiologies of colitis | typically, S. dysenteriae infections | 51,179 |
| nonsuppurative complications | |||
| reactive arthritis | Campylobacter, Salmonella, Shigella, Yersinia, | adult females, severe illness ±HLA-B27, ?PPIb, ?antibiotic administration, SNPc in IFNGd, duration of diarrhea |
108,180–184 106,107 |
| Guillain-Barré syndrome | Campylobacter jejuni | males ~1.5 × females. molecular mimicry of lipopolysaccharides of some strains and host gangliosides. SNPs in some host genes may contribute. | 185 |
| erythema nodosum | Yersinia, Shigella, Salmonella | 90,186,187 | |
| sequelae of enteric infections in low-middle income countries | |||
| tropical sprue | ?toxin-producing E. coli/Enterobacteriaciae | expatriates with extended exposure (e.g., Peace Corp volunteers) and residents of LMICs | 114–116,119,124,125 |
| environmental enteric dysfunction | ETECe and DECf pathovars, Shigella, Campylobacter | young children in LMICs | 133,134,137,139 |
LMIC low-middle income country
PPI proton pump inhibitor
SNP single nucleotide polymorphism
INFG interferon gamma gene
ETEC enterotoxigenic E. coli,
DEC diarrheagenic E. coli